XNAS 24 Jun, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Wendy B. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,925 | 10,925 | - | - | Stock Option (Right to Buy) | |
| Raymond Sanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,925 | 10,925 | - | - | Stock Option (Right to Buy) | |
| Reid M. Huber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 21,850 | 21,850 | - | - | Stock Option (Right to Buy) | |
| Paul M. Silva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,925 | 10,925 | - | - | Stock Option (Right to Buy) | |
| James I. Healy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 21,850 | 21,850 | - | - | Stock Option (Right to Buy) | |
| Steven M. Paul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 21,850 | 21,850 | - | - | Stock Option (Right to Buy) | |
| Robert J. Perez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 10,925 | 10,925 | - | - | Stock Option (Right to Buy) | |
| John M. Maraganore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 21,850 | 21,850 | - | - | Stock Option (Right to Buy) | |
| David Bredt | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 16 Jun 2025 | 8,500 | 443,642 | - | 11.0 | 93,522 | Common Stock |
| David Bredt | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.56 per share. | 15 May 2025 | 8,500 | 452,142 | - | 9.6 | 81,262 | Common Stock |
| David Bredt | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.57 per share. | 15 Apr 2025 | 8,500 | 460,642 | - | 9.6 | 81,310 | Common Stock |
| Jeffrey Sevigny | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| David Bredt | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.85 per share. | 14 Mar 2025 | 8,500 | 469,142 | - | 10.8 | 92,205 | Common Stock |
| Wendy B. Young | Director | Purchase of securities on an exchange or from another person at price $ 10.21 per share. | 12 Mar 2025 | 6,000 | 6,000 | - | 10.2 | 61,250 | Common Stock |
| Troy A. Ignelzi | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 12 Mar 2025 | 9,900 | 9,900 | - | 10.1 | 99,990 | Common Stock |
| Troy A. Ignelzi | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 9.98 per share. | 12 Mar 2025 | 100 | 10,000 | - | 10.0 | 998 | Common Stock |
| Cheryl Gault | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 13,987 | 171,928 | - | 0 | Common Stock | |
| Swamy Yeleswaram | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| David Bredt | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cheryl Gault | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 129,000 | 129,000 | - | - | Stock Option (Right to Buy) | |
| Abraham N. Ceesay | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 428,000 | 428,000 | - | - | Stock Option (Right to Buy) | |
| Troy A. Ignelzi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 142,000 | 142,000 | - | - | Stock Option (Right to Buy) | |
| Wendy B. Young | Director | 07 Nov 2024 | 29,756 | 29,756 | - | - | Stock Option (Right to Buy) | ||
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 26.06 per share. | 01 Jul 2024 | 2,625 | 40,851 | - | 26.1 | 68,395 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 23.08 per share. | 01 Jul 2024 | 3,630 | 29,908 | - | 23.1 | 83,764 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 25.02 per share. | 01 Jul 2024 | 4,661 | 38,226 | - | 25.0 | 116,598 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 24.21 per share. | 01 Jul 2024 | 3,657 | 33,565 | - | 24.2 | 88,543 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 25.02 per share. | 01 Jul 2024 | 4,544 | 37,102 | - | 25.0 | 113,671 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 24.21 per share. | 01 Jul 2024 | 3,565 | 32,558 | - | 24.2 | 86,316 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 23.08 per share. | 01 Jul 2024 | 3,538 | 28,993 | - | 23.1 | 81,641 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 26.06 per share. | 01 Jul 2024 | 2,559 | 39,661 | - | 26.1 | 66,675 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 23.08 per share. | 01 Jul 2024 | 3,799 | 21,660 | - | 23.1 | 87,664 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 24.21 per share. | 01 Jul 2024 | 3,828 | 25,488 | - | 24.2 | 92,684 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 25.02 per share. | 01 Jul 2024 | 4,878 | 30,366 | - | 25.0 | 122,026 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 26.05 per share. | 01 Jul 2024 | 2,748 | 33,114 | - | 26.1 | 71,599 | Common Stock |
| James I. Healy | Director | 10 Jun 2024 | 1,392,738 | 1,392,738 | - | 0 | Common Stock | ||
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Jun 2024 | 17,861 | 17,861 | - | 17 | 303,637 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Jun 2024 | 470,589 | 1,863,327 | - | 17 | 8,000,013 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Jun 2024 | 18,641 | 18,641 | - | 17 | 316,897 | Common Stock |
| James I. Healy | Director | 10 Jun 2024 | 11,924,138 | 0 | - | - | Series B Preferred Stock | ||
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Jun 2024 | 25,455 | 25,455 | - | 17 | 432,735 | Common Stock |
| James I. Healy | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 10 Jun 2024 | 26,278 | 26,278 | - | 17 | 446,726 | Common Stock |
| Bradley S. Galer | Chief Medical Officer | 06 Jun 2024 | 123,818 | 123,818 | - | - | Stock Option (Right to Buy) | ||
| Troy A. Ignelzi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 81,366 | 81,366 | - | - | Stock Option (Right to Buy) | |
| Abraham N. Ceesay | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 530,647 | 530,647 | - | - | Stock Option (Right to Buy) | |
| Cheryl Gault | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 88,442 | 88,442 | - | - | Stock Option (Right to Buy) | |
| David Bredt | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 28,302 | 28,302 | - | - | Stock Option (Right to Buy) | |
| Swamy Yeleswaram | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 84,904 | 84,904 | - | - | Stock Option (Right to Buy) |